The flow cytometric analysis of total p53 protein content and proliferation indices in colorectal cancer, in relation to clinical outcome

European Journal of Surgical Oncology

Volumn 22, Issue 5, 1996, Pages 508-515

  Rew, D A ^a,e   Karkera, R ^b   Mullee, M A ^f   Julious, S A ^c   Wilson, G D ^d  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d Gray Cancer Laboratory   (United Kingdom)

^e GLENFIELD HOSPITAL   (United Kingdom)

^f NONE

Author keywords

Colorectal cancer; Flow cytometry; p53; Proliferation indices

Indexed keywords

ALCOHOL; BROXURIDINE; MONOCLONAL ANTIBODY; PROTEIN P53; PYRIMIDINE;

ARTICLE; CANCER STAGING; CELL CYCLE PHASE; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; LABELING INDEX; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TREATMENT OUTCOME;

EID: 0029902863     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0748-7983(96)93027-9     Document Type: Article

References (27)

1. Donehower LA, Bradley A. The tumour suppressor p53. Biochim Biophys Acta 1993; 1155: 181-205.
2. Marx J. Cell death studies yield cancer clues. Science 1993; 259: 760-1.
3. Baker SJ, Markowitz S, Fearon E, Willson JKV, Vogelstein B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 1990; 249: 912-5.
4. Lane DP, Benchimol S. p53: oncogene or anti-oncogene? Genes and Development. 4: 1-8. Cold Spring Harbor Laboratory Press. 1990.
5. Harris CC. p53: at the crossroads of molecular carcinogenesis and risk assessment. Science 1993; 262: 1980-1.
6. Vogelstein B, Kinzler KW. Xrays strike p53 again. Nature 1994; 370: 174-5.
7. Vile RG. p53: à gene for all tumours? Br Med J 1993; 307: 1226-7.
8. Iggo R, Gatter K, Bartek J, Lane DP, Harris AL. Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 1990; 335: 675-9.
9. Baker SJ, Fearon ER, Nigro JM, et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 1989; 244: 217-21.
10. Kerr IB. Molecular genetics of colorectal carcinoma. Br Med J 1989; 299: 637-8.
11. Rodrigues NR, Rowan A, Smith ME, Kerr IB, Bodmer WF, Gannon JV, Lane DP. p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 1990; 87: 7555-9.
12. Shirasawa S, Urabe, K. Yanagawa Y, Toshitani K, Iwama T, Sasazuki T. p53 gene mutations in colorectal tumours from patients with familial polyposis coli. Cancer Res 1991; 51: 2874-8.
13. Van den Berg FM, Tigges AJ, Schipper MEJ, den Hartog-Jager FCA, Kroes WGM, Walboomers JMM. Expression of hte nuclear oncogene p53 in colon tumours. J Pathol 1989; 157: 193-9.
14. Scott N, Sagar P, Stewart J, Blair GE, Dixon MF, Quirkc P. p53 in colorectal cancer: clinicopathological correlation and prognostic significance. Br J Cancer 1991; 63: 317-9.
15. Sun X-F, Carstensen JM, Zhang H, et al. Prognostic significance of cytoplasmic p53 oncoprotein in colorectal carcinoma. Lancet 1992; 340: 1369-73.
16. Wynford-Thomas D. p53 in tumour pathology: can we trust immunocytochemistry? J Pathol 1992; 166: 329-30.
17. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Rex 1991; 51: 6304-11.
18. Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB. Wild type p53 is a cell cycle determinant following irradiation. Proc Natl Acad Sci USA 1992; 89: 7491-5.
19. Khochbin S, Chabanas A, Albert P, Lawrence JJ. Flow cytometric determination of protein distribution through the cell cycle. Cytometry 1989; 10: 484-9.
20. Rew DA, Taylor I, Watson JV, Wilson GD. The c-myc protein product is a marker of DNA synthesis but not of malignancy in gastrointestinal tissues and tumours. Br J Surg 1991: 78: 1080-3.
21. Watson JV, Stewart J, Cox C, Sikora K, Evan GI. Flow cytometric quantitation of the c-myc oncoprotein in archival neoplastic biopsies of the colon. Mol Cell Probes 1987; 1: 151-7.
22. Watson JV. An Introduction to Flow Cytometry. Cambridge: Cambridge University Press. 1992.
23. Morkve O, Laerum OD. Flow cytometric measurement of p53 protein expression and DNA content in paraffin embedded tissue from bronchial carcinomas. Cytometry 1991; 12: 438-44.
24. Remvikos Y, Laurent-Puig P, Salmon RJ, Frelat G, Dutrillaux B, Thomas G. Simultaneous monitoring of p53 protein and DNA content of colorectal adenocarcinomas by flow cytometry. Int J Cancer 1990: 45: 450-6.
25. Remvikos Y, Tominaga O, Hammel P, Laurent-Puig P, Salmon RJ, Dutrillaux B, Thomas G. Increased p53 protein content of colorectal tumours correlates with poor survival. Br J Cancer 1992; 66: 758-64.
26. Sawtell R, Rew DA, Stradling R, Wilson GD. A comparative flow and histometric study of proliferating cell nuclear antigen (PCNA) expression and bromodeoxyuridine labelling in colorectal cancer. Clin Comm Cytomet 1995; 22: 190-9.
27. Rew DA, Taylor I, Weaver PC, Wilson GD. The in vivo proliferation of human colorectal carcinomas. Br J Surg 1991; 78: 61-6.